(Q38367422)

2 September 2017

1 reference

title

Oxidative Stress and Aberrant Cell Cycle in Alzheimer's Disease Lymphocytes: Diagnostic Prospects (English)

1 reference

2 September 2017

0 references

0 references

5

1 reference

Katarzyna Laskowska-Kaszub

2 September 2017

Angeles Martín-Requero

object named as

Angeles Martín-Requero

series ordinal

4

0 references

series ordinal

3

object named as

Katarzyna Laskowska-Kaszub

1 reference

2 September 2017

1

Joanna Wojsiat

1 reference

2 September 2017

Chiara Prandelli

2

1 reference

2 September 2017

publication date

3 March 2015

1 reference

Journal of Alzheimer's Disease

2 September 2017

published in

1 reference

2 September 2017

volume

46

1 reference

2 September 2017

issue

2

1 reference

2 September 2017

page(s)

329-350

1 reference

The toxic Aβ oligomer and Alzheimer's disease: an emperor in need of clothes

2 September 2017

cites work

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141977

Correlation of Alzheimer disease neuropathologic changes with cognitive status: a review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141977

Biochemistry and cell biology of tau protein in neurofibrillary degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141977

The dark sides of amyloid in Alzheimer's disease pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141977

Antiamyloid therapy for Alzheimer's disease--are we on the right road?

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141977

Preventing Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141977

Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid beta-peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141977

The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141977

Oxidative stress, perturbed calcium homeostasis, and immune dysfunction in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141977

Inflammation, defective insulin signaling, and neuronal dysfunction in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141977

The complexities of the pathology-pathogenesis relationship in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141977

Deciphering the mechanism underlying late-onset Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141977

Calcium signalling and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141977

Reimagining Alzheimer's disease--an age-based hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141977

Linking Abeta and tau in late-onset Alzheimer's disease: a dual pathway hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141977

Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141977

Neuropathology of nondemented aging: presumptive evidence for preclinical Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141977

Combining early markers strongly predicts conversion from mild cognitive impairment to Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141977

Neuropsychological prediction of conversion to Alzheimer disease in patients with mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141977

Mild Cognitive Impairment Can Be Distinguished From Alzheimer Disease and Normal Aging for Clinical Trials

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141977

Blood markers of oxidative stress in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141977

Downregulation of extracellular signal-regulated kinase 1/2 activity by calmodulin KII modulates p21Cip1 levels and survival of immortalized lymphocytes from Alzheimer's disease patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141977

Neuronal failure in Alzheimer's disease: a view through the oxidative stress looking-glass

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141977

Peripheral mitochondrial dysfunction in Alzheimer's disease: focus on lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141977

Mitochondrion-derived reactive oxygen species lead to enhanced amyloid beta formation

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141977

Analysis of calcium homeostasis in fresh lymphocytes from patients with sporadic Alzheimer's disease or mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141977

Mutagenesis mapping of the presenilin 1 calcium leak conductance pore

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141977

Enhanced ROS generation mediated by Alzheimer's disease presenilin regulation of InsP3R Ca2+ signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141977

Presenilin-dependent expression of STIM proteins and dysregulation of capacitative Ca2+ entry in familial Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141977

Oxidative stress induces DNA demethylation and histone acetylation in SH-SY5Y cells: potential epigenetic mechanisms in gene transcription in Aβ production

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141977

The role of insulin resistance in the pathogenesis of Alzheimer's disease: implications for treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141977

Demonstrated brain insulin resistance in Alzheimer's disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141977

Cellular cofactors potentiating induction of stress and cytotoxicity by amyloid beta-peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141977

Geniposide attenuates oligomeric Aβ(1-42)-induced inflammatory response by targeting RAGE-dependent signaling in BV2 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141977

Abnormal mitochondrial dynamics and synaptic degeneration as early events in Alzheimer's disease: implications to mitochondria-targeted antioxidant therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141977

Aging and amyloid beta-induced oxidative DNA damage and mitochondrial dysfunction in Alzheimer's disease: implications for early intervention and therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141977

In vivo oxidative stress in brain of Alzheimer disease transgenic mice: Requirement for methionine 35 in amyloid beta-peptide of APP.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141977

Elevated levels of 4-hydroxynonenal-histidine Michael adduct in the hippocampi of patients with Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141977

Intraneuronal amyloid beta accumulation and oxidative damage to nucleic acids in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141977

Roles of 3-nitrotyrosine- and 4-hydroxynonenal-modified brain proteins in the progression and pathogenesis of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141977

Conformational altered p53 as an early marker of oxidative stress in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141977

CD4 T cells in immunity and immunotherapy of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141977

Amyloid beta, mitochondrial structural and functional dynamics in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141977

Oxidatively modified, mitochondria-relevant brain proteins in subjects with Alzheimer disease and mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141977

Oxidative stress and mitochondrial dysfunction in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141977

Elevation of glutathione as a therapeutic strategy in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141977

Beyond amyloid: getting real about nonamyloid targets in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141977

Cell cycle activation and aneuploid neurons in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141977

Cell cycle deregulation in the neurons of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141977

Dysfunction of the mTOR pathway is a risk factor for Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141977

Repair of oxidative DNA damage, cell-cycle regulation and neuronal death may influence the clinical manifestation of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141977

Adult neurogenesis in brain repair: cellular plasticity vs. cellular replacement.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141977

Cell cycle activation and CNS injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141977

Review: cell cycle aberrations and neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141977

Role of cell cycle proteins in CNS injury

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141977

Cell cycle inhibition provides neuroprotection and reduces glial proliferation and scar formation after traumatic brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141977

DNA damage and cell cycle events implicate cerebellar dentate nucleus neurons as targets of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141977

p53 and Cell Cycle Proteins Participate in Spinal Motor Neuron Cell Death in ALS

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141977

Neuronal CDK7 in hippocampus is related to aging and Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141977

Neuronal aneuploidy in health and disease: a cytomic approach to understand the molecular individuality of neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141977

Increased p27, an essential component of cell cycle control, in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141977

Constitutive expression of functionally active cyclin-dependent kinases and their binding partners suggests noncanonical functions of cell cycle regulators in differentiated neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141977

Aneuploidy and DNA replication in the normal human brain and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141977

A novel hypothesis for Alzheimer disease based on neuronal tetraploidy induced by p75 (NTR).

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141977

Abeta oligomers induce neuronal cell cycle events in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141977

Neural cell cycle dysregulation and central nervous system diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141977

Causes versus effects: the increasing complexities of Alzheimer's disease pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141977

Alzheimer disease, the two-hit hypothesis: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141977

Cell cycle checkpoint abnormalities during dementia: A plausible association with the loss of protection against oxidative stress in Alzheimer's disease [corrected].

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141977

Checkpoints: it takes more than time to heal some wounds

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141977

DNA repair/pro-apoptotic dual-role proteins in five major DNA repair pathways: fail-safe protection against carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141977

Apoptosis or senescence-like growth arrest: influence of cell-cycle position, p53, p21 and bax in H2O2 response of normal human fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141977

Cell cycle activation in postmitotic neurons is essential for DNA repair.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141977

Oxidative DNA damage in peripheral leukocytes of mild cognitive impairment and AD patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141977

Lymphocytes of patients with Alzheimer's disease display different DNA damage repair kinetics and expression profiles of DNA repair and stress response genes

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141977

Oxidative stress activates the transcription factors FoxO 1a and FoxO 3a in the hippocampus of rats exposed to low doses of ozone

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141977

Brain-derived neurotrophic factor inhibits cell cycle reentry but not endoplasmic reticulum stress in cultured neurons following oxidative or excitotoxic stress

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141977

Re-entry into the cell cycle: a mechanism for neurodegeneration in Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141977

Correlation between behavioural and psychological symptoms of Alzheimer type dementia and plasma homocysteine concentration

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141977

Dysregulation of the hypothalamic-pituitary-gonadal axis with menopause and andropause promotes neurodegenerative senescence

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141977

Gender differences in Alzheimer disease: the role of luteinizing hormone in disease pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141977

Direct exposure of guinea pig CNS to human luteinizing hormone increases cerebrospinal fluid and cerebral beta amyloid levels

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141977

Advanced glycation end products are mitogenic signals and trigger cell cycle reentry of neurons in Alzheimer's disease brain

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141977

The unfolded protein response affects neuronal cell cycle protein expression: implications for Alzheimer's disease pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141977

Microglial derived tumor necrosis factor-α drives Alzheimer's disease-related neuronal cell cycle events

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141977

MiR-26b, upregulated in Alzheimer's disease, activates cell cycle entry, tau-phosphorylation, and apoptosis in postmitotic neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141977

Conditional neuronal simian virus 40 T antigen expression induces Alzheimer-like tau and amyloid pathology in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141977

The neuronal expression of MYC causes a neurodegenerative phenotype in a novel transgenic mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141977

21 January 2018

Tau in MAPK activation

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141977

Tau potentiates nerve growth factor-induced mitogen-activated protein kinase signaling and neurite initiation without a requirement for microtubule binding.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141977

The cell cycle as a therapeutic target for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141977

The amyloid protein precursor of Alzheimer's disease is a mediator of the effects of nerve growth factor on neurite outgrowth

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141977

Glucagon-like peptide-1 (GLP-1) diminishes neuronal degeneration and death caused by NGF deprivation by suppressing Bim induction.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141977

Modulation of amyloid precursor protein cleavage by cellular sphingolipids

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141977

Alzheimer amyloid protein precursor complexes with brain GTP-binding protein G(o)

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141977

Divide and die: cell cycle events as triggers of nerve cell death.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141977

The amyloid precursor protein-binding protein APP-BP1 drives the cell cycle through the S-M checkpoint and causes apoptosis in neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141977

Amyloid precursor protein and Presenilin1 interact with the adaptor GRB2 and modulate ERK 1,2 signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141977

Alzheimer presenilins in the nuclear membrane, interphase kinetochores, and centrosomes suggest a role in chromosome segregation

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141977

Familial Alzheimer's disease presenilin-1 mutants potentiate cell cycle arrest

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141977

Presenilin 1 negatively regulates beta-catenin/T cell factor/lymphoid enhancer factor-1 signaling independently of beta-amyloid precursor protein and notch processing

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141977

Ca2+/calmodulin-dependent modulation of cell cycle elements pRb and p27kip1 involved in the enhanced proliferation of lymphoblasts from patients with Alzheimer dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141977

Platelet as a physiological model to investigate apoptotic mechanisms in Alzheimer beta-amyloid peptide production

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141977

Multivariate analysis of differential lymphocyte cell cycle activity in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141977

Cell cycle kinesis in lymphocytes in the diagnosis of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141977

Cell cycle regulation distinguishes lymphocytes from sporadic and familial Alzheimer's disease patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141977

G1/S checkpoint proteins in peripheral blood lymphocytes are potentially diagnostic biomarkers for Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141977

P53-mediated G(1)/S checkpoint dysfunction in lymphocytes from Alzheimer's disease patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141977

The dysregulation of the cell cycle and the diagnosis of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141977

Cyclin D1 and cyclin E are co-localized with cyclo-oxygenase 2 (COX-2) in pyramidal neurons in Alzheimer disease temporal cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141977

Activation of the unfolded protein response is an early event in Alzheimer's and Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141977

Cell cycle regulation in the postmitotic neuron: oxymoron or new biology?

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141977

Altered cell cycle-related gene expression in brain and lymphocytes from a transgenic mouse model of Alzheimer's disease [amyloid precursor protein/presenilin 1 (PS1)].

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141977

Antagonistic pleiotropy and p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141977

Role of p21 in SP600125-induced cell cycle arrest, endoreduplication, and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141977

p21(WAF1/CIP1) and cancer: a shifting paradigm?

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141977

Constitutive hyperexpression of p21(WAF1) in human U266 myeloma cells blocks the lethal signaling induced by oxidative stress but not by Fas.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141977

Impaired apoptosis in lymphoblasts from Alzheimer's disease patients: cross-talk of Ca2+/calmodulin and ERK1/2 signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141977

Enhanced proteasome-dependent degradation of the CDK inhibitor p27(kip1) in immortalized lymphocytes from Alzheimer's dementia patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141977

Altered transcriptional regulators in response to serum in immortalized lymphocytes from Alzheimer's disease patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141977

Contribution of p53 to metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141977

Stochasticity of intranuclear biochemical reaction processes controls the final decision of cell fate associated with DNA damage

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141977

New insights into p53 functions through its target microRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141977

Puma is an essential mediator of p53-dependent and -independent apoptotic pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141977

p53 functional inhibitors behaving like pifithrin-β counteract the Alzheimer peptide non-β-amyloid component effects in human SH-SY5Y cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141977

Conformationally altered p53: a novel Alzheimer's disease marker?

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141977

Conformational altered p53 affects neuronal function: relevance for the response to toxic insult and growth-associated protein 43 expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141977

Redox signalling and transition metals in the control of the p53 pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141977

Nerve growth factor restores p53 function in pituitary tumor cell lines via trkA-mediated activation of phosphatidylinositol 3-kinase.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141977

Impairment of mitogenic activation of peripheral blood lymphocytes in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141977

Mitotic activation: a convergent mechanism for a cohort of neurodegenerative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141977

Alteration in cell cycle-related proteins in lymphoblasts from carriers of the c.709-1G>A PGRN mutation associated with FTLD-TDP dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141977

PGRN haploinsufficiency increased Wnt5a signaling in peripheral cells from frontotemporal lobar degeneration-progranulin mutation carriers.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141977

Calmodulin levels in blood cells as a potential biomarker of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141977

Altered calmodulin degradation and signaling in non-neuronal cells from Alzheimer's disease patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141977

Classification and prediction of clinical diagnosis of Alzheimer's disease based on MRI and plasma measures of α-/γ-tocotrienols and γ-tocopherol.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141977

Mitochondrial fission proteins in peripheral blood lymphocytes are potential biomarkers for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141977

Lymphocyte mitochondria: toward identification of peripheral biomarkers in the progression of Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141977

Effect of cognitive training on the expression of brain-derived neurotrophic factor in lymphocytes of mild cognitive impairment patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141977

Increased expression of interleukin-18 receptor in blood cells of subjects with mild cognitive impairment and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141977

Clinical relevance of specific T-cell activation in the blood and cerebrospinal fluid of patients with mild Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141977

Imaging, subjective complaints, and MCI: 30 years before

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141977

Efficacy of cyclin dependent kinase 4 inhibitors as potent neuroprotective agents against insults relevant to Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141977

Silencing of CDK5 as potential therapy for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141977

Inhibition of Polo-like kinase 1 reduces beta-amyloid-induced neuronal cell death in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141977

Simvastatin overcomes the resistance to serum withdrawal-induced apoptosis of lymphocytes from Alzheimer's disease patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141977

The neuroprotective effect of two statins: simvastatin and pravastatin on a streptozotocin-induced model of Alzheimer's disease in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141977

Mitochondrial dysfunction--a pharmacological target in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141977

Mitochondrial dynamics in Alzheimer's disease: opportunities for future treatment strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141977

Dimebon attenuates the Aβ-induced mitochondrial permeabilization

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141977

Latrepirdine: molecular mechanisms underlying potential therapeutic roles in Alzheimer's and other neurodegenerative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141977

Estrogen regulation of mitochondrial bioenergetics: implications for prevention of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141977

Estrogen regulation of glucose metabolism and mitochondrial function: therapeutic implications for prevention of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141977

Dibenzo[1,4,5]thiadiazepine: a hardly-known heterocyclic system with neuroprotective properties of potential usefulness in the treatment of neurodegenerative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141977

Therapeutic benefits of H₂S in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141977

Hydrogen sulfide protects against amyloid beta-peptide induced neuronal injury via attenuating inflammatory responses in a rat model

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141977

Hydrogen sulfide slows down progression of experimental Alzheimer's disease by targeting multiple pathophysiological mechanisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141977

Bid-mediated mitochondrial damage is a key mechanism in glutamate-induced oxidative stress and AIF-dependent cell death in immortalized HT-22 hippocampal neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141977

Bid mediates fission, membrane permeabilization and peri-nuclear accumulation of mitochondria as a prerequisite for oxidative neuronal cell death.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141977

Bid-induced release of AIF from mitochondria causes immediate neuronal cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141977

N-acyl derivatives of 4-phenoxyaniline as neuroprotective agents

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141977

Kaempferol attenuates the glutamate-induced oxidative stress in mouse-derived hippocampal neuronal HT22 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141977

Gene expression profile associated with oncogenic ras-induced senescence, cell death, and transforming properties in human cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141977

Trade-off between cancer and aging: what role do other diseases play? Evidence from experimental and human population studies

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141977

Inverse occurrence of cancer and Alzheimer disease: a population-based incidence study

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141977

21 January 2018

Identifiers

DOI

10.3233/JAD-141977

1 reference

2 September 2017

1 reference